NASDAQ:OBME

Orchestra BioMed Shares Trade Lower Ahead of Trial Milestone
····

Orchestra BioMed Shares Trade Lower Ahead of Trial Milestone

Orchestra BioMed shares fell 0.8% to $3.95 Friday afternoon, underperforming the SPDR S&P Biotech ETF’s 0.4% gain. The company expects to finish enrollment for its BACKBEAT pivotal trial by the end of Q3 2026. Management will appear at the Jefferies Global Healthcare Conference on June 4. Cash holdings stood at $94.4 million at the end of March, with an additional $35 million received in May.
May 29, 2026

Stock Market Today

  • Top 3 ASX Dividend Shares to Buy in June for Reliable Income
    May 29, 2026, 3:14 PM EDT. June presents income investors with opportunities in three top ASX dividend shares: APA Group, Telstra, and Transurban. APA Group, a key player in Australia's energy infrastructure, offers a forecast 5.7% dividend yield for FY 2027. Telstra, Australia's leading telco, provides essential mobile connectivity with a 4.1% forward dividend yield, supported by its dominant network. Transurban operates critical toll roads in Australia and North America, with expected dividend yield also at 4.1% in FY 2027. These shares offer resilient cash flows and defensive characteristics, appealing amid varied market conditions.